OLVIG
Oliver Lagore Vanvalin Investment Group’s Heart Test Laboratories HSCS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-305
| Closed | -$1.48K | – | 697 |
|
|
2024
Q3 | $1.48K | Sell |
305
-180
| -37% | -$873 | ﹤0.01% | 597 |
|
|
2024
Q2 | $2.53K | Sell |
485
-69,873
| -99% | -$364K | ﹤0.01% | 581 |
|
|
2024
Q1 | $8.23K | Sell |
70,358
-14,250
| -17% | -$1.67K | ﹤0.01% | 434 |
|
|
2023
Q4 | $14.5K | Buy |
84,608
+15,001
| +22% | +$2.57K | 0.01% | 358 |
|
|
2023
Q3 | $29.7K | Sell |
69,607
-43,247
| -38% | -$18.4K | 0.01% | 295 |
|
|
2023
Q2 | $102K | Sell |
112,854
-43,776
| -28% | -$39.6K | 0.04% | 169 |
|
|
2023
Q1 | $155K | Sell |
156,630
-5,214
| -3% | -$5.15K | 0.07% | 98 |
|
|
2022
Q4 | $136K | Buy |
161,844
+136,844
| +547% | +$115K | 0.08% | 104 |
|
|
2022
Q3 | $30K | Buy |
+25,000
| New | +$30K | 0.02% | 215 |
|